| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison in Dissolution Profiles between Extended-Release and Wax-Matrix Niacin
|
Ito, Matthew K.
|
|
2014
|
8 |
3 |
p. 351-352
2 p.
|
artikel
|
| 2 |
After 52 Weeks, Pitavastatin Superior to Pravastatin on LDL-C Lowering in Patients with HIV†
|
Sponseller, Craig A.
|
|
2014
|
8 |
3 |
p. 333-334
2 p.
|
artikel
|
| 3 |
A Kindred with Fish Eye Disease, Corneal Opacities, Marked High Density Lipoprotein Defieciency, and Statin Therapy†
|
Dimick, Susan M.
|
|
2014
|
8 |
3 |
p. 305-306
2 p.
|
artikel
|
| 4 |
Analysis of Lipoprotein Subclasses and Apolipoprotein Levels of African-American Males with Type 2 Diabetes
|
Ryan, Gina
|
|
2014
|
8 |
3 |
p. 299-
1 p.
|
artikel
|
| 5 |
An Antisense Inhibitor of Apolipoprotein C-III Substantially Decreases Fasting Apolipoprotein C-III and Triglyceride Levels in LPL Deficiency
|
Gaudet, Daniel
|
|
2014
|
8 |
3 |
p. 353-354
2 p.
|
artikel
|
| 6 |
An Investigation of Immediate Release Niacin Effect at Different Levels of LDL-C, HDL-C, Triglycerides, and Lipoprotein(a)*
|
Vo, Elise
|
|
2014
|
8 |
3 |
p. 348-349
2 p.
|
artikel
|
| 7 |
A Novel Total Lipoprotein Electronegativity Index for Predicting Cardiometabolic Risk*
|
Elyasi, Maekal
|
|
2014
|
8 |
3 |
p. 346-
1 p.
|
artikel
|
| 8 |
Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia
|
Shen, Zhe
|
|
2014
|
8 |
3 |
p. 273-278
6 p.
|
artikel
|
| 9 |
Association Between Changes in LDL-C, Non-HDL Cholesterol, Apolipoprotein B Levels and Coronary Plaque Regression
|
Siniawski, Daniel Alberto
|
|
2014
|
8 |
3 |
p. 318-319
2 p.
|
artikel
|
| 10 |
Association Between Fasting Triglycerides and Presence of Fasting Chylomicrons in Patients with Severe Hypertriglyceridemia
|
Kjems, Lise
|
|
2014
|
8 |
3 |
p. 312-313
2 p.
|
artikel
|
| 11 |
Association Between Low Density Lipoprotein Cholesterol or Low Density Lipoprotein Particle Concentration and Metabolic Syndrome and High Sensitivity C-Reactive Protein in Retired National Football League Players*
|
Pokharel, Yashashwi
|
|
2014
|
8 |
3 |
p. 357-358
2 p.
|
artikel
|
| 12 |
Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: The role of interdisciplinary therapy
|
Sanches, Priscila L.
|
|
2014
|
8 |
3 |
p. 265-272
8 p.
|
artikel
|
| 13 |
Association of Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein-Associated Phospholipase A2 with Carotid Plaque Characteristics in the Atherosclerosis Risk in Communities Study*
|
Pokharel, Yashashwi
|
|
2014
|
8 |
3 |
p. 319-321
3 p.
|
artikel
|
| 14 |
Atherosclerotic Cardiovascular Disease in African-Americans: More than LDL Lowering*
|
Jarrett, Harish
|
|
2014
|
8 |
3 |
p. 335-
1 p.
|
artikel
|
| 15 |
Atherothrombotic Outcomes When Lipid Target Goals Are Not Met
|
Feeman Jr., W. E. (William E.)
|
|
2014
|
8 |
3 |
p. 322-
1 p.
|
artikel
|
| 16 |
Calcified Plaque is Associated with Less Neovascularization and Lower Permeability as Assessed by Dynamic Contrast Enhanced MRI
|
Gill, Edward A.
|
|
2014
|
8 |
3 |
p. 343-344
2 p.
|
artikel
|
| 17 |
Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
|
Fekih, Ons
|
|
2014
|
8 |
3 |
p. 249-255
7 p.
|
artikel
|
| 18 |
Carotid Vessel Wall Volume Decreases with Intensive Lipid Therapy in Plaque with and without Lipid Rich Necrotic Core
|
Gill, Edward A.
|
|
2014
|
8 |
3 |
p. 344-345
2 p.
|
artikel
|
| 19 |
Changes in Fasting Glucose Levels Following Longer-Term Treatment with Simvastatin Monotherapy and Combined Ezetimibe+Simvastatin†
|
Toth, Peter P.
|
|
2014
|
8 |
3 |
p. 299-300
2 p.
|
artikel
|
| 20 |
Changes in LDL and Cholesterol Retention Fraction and Plaque Non-Progression in Program on the Surgical Control of Hyperlipidemia
|
Feeman Jr., W. E. (William E.)
|
|
2014
|
8 |
3 |
p. 321-322
2 p.
|
artikel
|
| 21 |
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study
|
Cho, Leslie
|
|
2014
|
8 |
3 |
p. 335-336
2 p.
|
artikel
|
| 22 |
COLT, Multicenter CaPre Open Label Randomized Dose-Ranging Phase II Trial to Assess Efficacy/Safety in Patients with Mild-to-High Hypertriglyceridemia
|
Sampalis, Tina
|
|
2014
|
8 |
3 |
p. 317-318
2 p.
|
artikel
|
| 23 |
Combination Eicosapentaenoic Acid and Statin Treatment Reversed Endothelial Dysfunction in HUVECs Exposed to Oxidized LDL
|
Mason, R. Preston
|
|
2014
|
8 |
3 |
p. 342-343
2 p.
|
artikel
|
| 24 |
Comparative Effectiveness of Rosuvastatin Versus Other Statins on Low-Density Lipoprotein Cholesterol (LDL-C) Reduction in Moderate-Risk Patients
|
Cziraky, Mark J.
|
|
2014
|
8 |
3 |
p. 325-326
2 p.
|
artikel
|
| 25 |
Comparison of Lipid Profiles and BMI by Age Groups in Acute Ischemic Stroke*
|
Doukas, Demetrios
|
|
2014
|
8 |
3 |
p. 303-304
2 p.
|
artikel
|
| 26 |
Contemporary Treatment of Homozygous Familial Hypercholesterolemia
|
Tully, Lisa
|
|
2014
|
8 |
3 |
p. 330-331
2 p.
|
artikel
|
| 27 |
Diacylglycerol Acyltransferase 1 (DGAT1) Inhibition as a Metabolic Regulator: Clinical Benefits of Pradigastat in Obese Patients with Type 2 Diabetes
|
Kjems, Lise
|
|
2014
|
8 |
3 |
p. 301-302
2 p.
|
artikel
|
| 28 |
Diagnosis and Cardiovascular Risk Factors in Dysbetalipoproteinemia: a Large Cohort Study*
|
Chen, Michael
|
|
2014
|
8 |
3 |
p. 302-303
2 p.
|
artikel
|
| 29 |
Diagnosis and Treatment Patterns of Real-World Patients with Severe Hypertriglyceridemia
|
Toth, Peter P.
|
|
2014
|
8 |
3 |
p. 314-315
2 p.
|
artikel
|
| 30 |
Donor Derived Familial Hypercholesterolemia and Impact Upon Clinical Outcomes
|
Heronemus, Marc
|
|
2014
|
8 |
3 |
p. 326-327
2 p.
|
artikel
|
| 31 |
Dose Effects of Ezetimibe/Simvastatin (E/S) Versus Atorvastatin (A) on Lipoprotein Subclasses
|
Le, Anh N.
|
|
2014
|
8 |
3 |
p. 349-
1 p.
|
artikel
|
| 32 |
Dyslipidemia and Insulin Resistance in Nondiabetic Subjects with Fatty Liver Disease
|
Wyne, Kathleen L.
|
|
2014
|
8 |
3 |
p. 347-348
2 p.
|
artikel
|
| 33 |
Dyslipidemia and Sustained Transaminase Elevations from Early Childhood are Common in Lysosomal Acid Lipase Deficiency
|
Tripuraneni, Radhika
|
|
2014
|
8 |
3 |
p. 306-307
2 p.
|
artikel
|
| 34 |
Editorial Board
|
|
|
2014
|
8 |
3 |
p. A1-A2
nvt p.
|
artikel
|
| 35 |
Effect of Sebelipase Alfa After 90 Weeks in Adults with Lysosomal Acid Lipase Deficiency
|
Tripuraneni, Radhika
|
|
2014
|
8 |
3 |
p. 354-355
2 p.
|
artikel
|
| 36 |
Effects of Apolipoprotein E Polymorphism on Plasma Lipoprotein (a) Levels and Cardiovascular Outcomes in Familial Hypercholesterolemia*
|
Chen, Michael
|
|
2014
|
8 |
3 |
p. 304-
1 p.
|
artikel
|
| 37 |
Effects of Evolocumab on Lipoprotein Particles & Subclasses in Hypercholesterolemic & Heterozygous Familial Hypercholesterolemia Subjects on Statin†
|
Xu, Ren
|
|
2014
|
8 |
3 |
p. 350-351
2 p.
|
artikel
|
| 38 |
Eicosapentaenoic Acid Inhibited Glucose-Induced Membrane Lipid Peroxidation and Cholesterol Crystalline Domain Formation
|
Mason, R. Preston
|
|
2014
|
8 |
3 |
p. 343-
1 p.
|
artikel
|
| 39 |
ETC-1002 Lowers LDL-Cholesterol and is Well Tolerated in Hypercholesterolemic Patients Across Four Phase 2a Studies
|
Newton, Roger S.
|
|
2014
|
8 |
3 |
p. 339-340
2 p.
|
artikel
|
| 40 |
ETC-1002 Lowers LDL-Cholesterol and is Well Tolerated in Hypercholesterolemic Patients with Statin Intolerance†
|
Newton, Roger S.
|
|
2014
|
8 |
3 |
p. 340-341
2 p.
|
artikel
|
| 41 |
ETC-1002 Reduces Blood Pressure in Hypercholesterolemic Patients with Mildly Elevated Blood Pressure
|
Newton, Roger S.
|
|
2014
|
8 |
3 |
p. 350-
1 p.
|
artikel
|
| 42 |
Evaluation of Cardiovascular Events with the Administration of Mipomersen, an Antisense apo B–100 Synthesis Inhibitor: Results from the Phase 3 Program†
|
Santos, Raul D.
|
|
2014
|
8 |
3 |
p. 329-330
2 p.
|
artikel
|
| 43 |
Familial Hypercholesterolemia: A Role for Genetic Screening in Women†∗
|
Ahmad, Zahid
|
|
2014
|
8 |
3 |
p. 304-305
2 p.
|
artikel
|
| 44 |
From the Editor: The National Meeting of the NLA
|
Brown, W. Virgil
|
|
2014
|
8 |
3 |
p. 235-
1 p.
|
artikel
|
| 45 |
Gene Sequencing in US Patients with Severe Clinical Familial Hypercholesterolemia∗
|
Schoen, Marisa
|
|
2014
|
8 |
3 |
p. 307-309
3 p.
|
artikel
|
| 46 |
Genotype-phenotype relationships in patients with type I hyperlipoproteinemia
|
Chokshi, Neema
|
|
2014
|
8 |
3 |
p. 287-295
9 p.
|
artikel
|
| 47 |
Goal Attainment of Diabetes Quality Measures in an Era of Physician Quality Scorecards
|
Uusinarkaus, Kari
|
|
2014
|
8 |
3 |
p. 326-
1 p.
|
artikel
|
| 48 |
Icosapent Ethyl (eicosapentaenoic acid ethyl ester): Effects on Apolipoprotein C-III in Patients from the MARINE and ANCHOR Studies
|
Ballantyne, Christie M.
|
|
2014
|
8 |
3 |
p. 313-314
2 p.
|
artikel
|
| 49 |
Identifying Insulin Resistant Children Utilizing Lipoprotein-Based Measurements
|
Wilson, Don
|
|
2014
|
8 |
3 |
p. 300-301
2 p.
|
artikel
|
| 50 |
Immunoprecipitation of ApoB-Containing Lipoproteins and Comparison to Dextran Sulfate/Magnesium Chloride Precipitation
|
Contois, John H.
|
|
2014
|
8 |
3 |
p. 296-297
2 p.
|
artikel
|
| 51 |
Impact of a Paleolithic Diet on Modifiable Cardiovascular Risk Factors
|
Talreja, Deepak
|
|
2014
|
8 |
3 |
p. 341-
1 p.
|
artikel
|
| 52 |
Impact of High-Density Lipoprotein Cholesterol on Revascularization Procedures in Patients With Stable Ischemic Heart Disease: From the COURAGE trial*
|
Acharjee, Subroto
|
|
2014
|
8 |
3 |
p. 310-311
2 p.
|
artikel
|
| 53 |
Incidence and Characteristics of Acute Pancreatitis in a Real-World Sample of Patients with Severe Hypertriglyceridemia
|
Toth, Peter P.
|
|
2014
|
8 |
3 |
p. 316-317
2 p.
|
artikel
|
| 54 |
Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects
|
Anderson, Jacqueline M.
|
|
2014
|
8 |
3 |
p. 256-264
9 p.
|
artikel
|
| 55 |
Insulin Infusion Acutely Downregulates Circulating PCSK9 in Human*
|
Awan, Zuhier
|
|
2014
|
8 |
3 |
p. 302-
1 p.
|
artikel
|
| 56 |
Interaction between Cholesterol Crystals and Bacteria: Implications for Atherosclerosis *
|
Raju, Manjunath
|
|
2014
|
8 |
3 |
p. 346-347
2 p.
|
artikel
|
| 57 |
JCL Roundtable: Clinical management of individuals with obesity
|
Brown, W. Virgil
|
|
2014
|
8 |
3 |
p. 237-248
12 p.
|
artikel
|
| 58 |
Keeping Kids Young at Heart: Development of a Pediatric Preventive Cardiology Clinic*
|
Peterson, Amy Lynn Hering
|
|
2014
|
8 |
3 |
p. 327-328
2 p.
|
artikel
|
| 59 |
Knowledge of PCSK9 and Continued Educational Gaps: Evaluating the Impact of CME
|
Larkin, Amy
|
|
2014
|
8 |
3 |
p. 325-
1 p.
|
artikel
|
| 60 |
Lack of Fetal Harm and Absence of Drug-Drug Interactions Attributed to Unique Pharmacokinetic Properties of Mipomersen
|
Henry, Scott
|
|
2014
|
8 |
3 |
p. 328-
1 p.
|
artikel
|
| 61 |
Lipid Management and Physician Visit Patterns in a Real-World Sample of Patients with Severe Hypertriglyceridemia
|
Toth, Peter P.
|
|
2014
|
8 |
3 |
p. 315-316
2 p.
|
artikel
|
| 62 |
Lipoprotein Associated Phospholipase A2 Mass is Not Associated with Subclinical Coronary and Carotid Atherosclerosis in the Retired National Football League Players*
|
Pokharel, Yashashwi
|
|
2014
|
8 |
3 |
p. 345-346
2 p.
|
artikel
|
| 63 |
Lipoprotein Measurements in Patients Infected with HIV: Is Cholesterol Content of HDL and LDL Discordant with Particle Number?
|
Myerson, Merle
|
|
2014
|
8 |
3 |
p. 332-333
2 p.
|
artikel
|
| 64 |
Longer-Term Safety of Statin Therapy in Children and Adolescents with Heterozygous Familial Hypercholesterolemia Treated for >2 Years
|
McCrindle, Brian W.
|
|
2014
|
8 |
3 |
p. 331-
1 p.
|
artikel
|
| 65 |
Long-Term 40-Year Prognosis in Abetalipoproteinemia is Optimized by Early Diagnosis and Treatment
|
Duell, P. Bart
|
|
2014
|
8 |
3 |
p. 336-
1 p.
|
artikel
|
| 66 |
Low Density Lipoprotein Particle Concentration Measurement by the Vertical Lipoprotein Profile (VLP) Method
|
Kulkarni, Krishnaji R.
|
|
2014
|
8 |
3 |
p. 298-299
2 p.
|
artikel
|
| 67 |
Managing the Statin Intolerant Patient: Low-Dose/ Low-Frequency Treatment Regimens
|
Honkanen, Mary H.
|
|
2014
|
8 |
3 |
p. 338-339
2 p.
|
artikel
|
| 68 |
Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces LDL-C in HoFH Pediatric Patients†
|
Selvey, Sheryl
|
|
2014
|
8 |
3 |
p. 330-
1 p.
|
artikel
|
| 69 |
News from the NLA
|
|
|
2014
|
8 |
3 |
p. 236-
1 p.
|
artikel
|
| 70 |
Niacin Inhibits Fat Accumulation and Oxidative Stress in Human Hepatocytes and Regresses Hepatic Steatosis in Experimental Rat Model
|
Ganji, Shobha H.
|
|
2014
|
8 |
3 |
p. 349-350
2 p.
|
artikel
|
| 71 |
On-Treatment Triglyceride Concentration is a Determinant of the Change in LDL Particle Size During Therapy with Omega-3 Free Fatty Acids
|
Maki, Kevin C.
|
|
2014
|
8 |
3 |
p. 342-
1 p.
|
artikel
|
| 72 |
Pancreatitis in Severe Hypertriglyceridemia: Association of Gene Variants in Lipoprotein Lipase and Serine Protease Pathways with Increased Risk of Recurrent Hospitalizations*
|
Tremblay, Karine
|
|
2014
|
8 |
3 |
p. 312-
1 p.
|
artikel
|
| 73 |
Phase 1 Single and Multiple Ascending Dose Study of CAT-2003, a Novel Activator of Lipoprotein Lipase, Decreases Postprandial Triglycerides†
|
Donovan, Joanne M.
|
|
2014
|
8 |
3 |
p. 311-
1 p.
|
artikel
|
| 74 |
Physician Awareness of the Guidelines on Diagnosis of Metabolic Syndrome
|
Shan, Tamara
|
|
2014
|
8 |
3 |
p. 357-
1 p.
|
artikel
|
| 75 |
Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV Dyslipidemia: Post-Hoc Analysis of the INTREPID Trial Based on the Independent CHD Risk Factor of Age†
|
Sponseller, Craig A.
|
|
2014
|
8 |
3 |
p. 331-332
2 p.
|
artikel
|
| 76 |
Plasma Fatty Acids as Predictors of Triglyceride and Non-HDL Cholesterol Responses to Omega-3 Free Fatty Acid Therapy in Hypertriglyceridemia
|
Maki, Kevin C.
|
|
2014
|
8 |
3 |
p. 341-342
2 p.
|
artikel
|
| 77 |
Predicting the Population at Risk of Atherothrombotic Disease
|
Feeman Jr., W. E. (William E.)
|
|
2014
|
8 |
3 |
p. 322-323
2 p.
|
artikel
|
| 78 |
Residual Dyslipidemia According to LDL-C, Non-HDL-C and Apolipoprotein B by Cardiovascular Risk Category in Statin Treated US Adults
|
Wong, Nathan D.
|
|
2014
|
8 |
3 |
p. 323-324
2 p.
|
artikel
|
| 79 |
Rhabdomyolysis in a Patient Taking Colchicine and Rosuvastatin*
|
Carral, Joaquin
|
|
2014
|
8 |
3 |
p. 352-353
2 p.
|
artikel
|
| 80 |
Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study
|
Esteghamati, Alireza
|
|
2014
|
8 |
3 |
p. 279-286
8 p.
|
artikel
|
| 81 |
Rosuvastatin Inhibits Myeloperoxidase (MPO) in Human Leukocytic Cells
|
Ganji, Shobha H.
|
|
2014
|
8 |
3 |
p. 310-
1 p.
|
artikel
|
| 82 |
Simvastatin and CCBs: A Comparison of Prescribing Practices Before and After the U.S. FDA Updates to the 2011 Simvastatin Dosing Standards*
|
Tuchscherer, Rhianna
|
|
2014
|
8 |
3 |
p. 334-
1 p.
|
artikel
|
| 83 |
Statins and Cognitive Function: A Systematic Review†∗
|
Schoen, Marisa
|
|
2014
|
8 |
3 |
p. 336-338
3 p.
|
artikel
|
| 84 |
Statin Treated Patients at Very High Cardiovascular Risk: Are the Majority Close to LDL-C <70 mg/dl?
|
Lautsch, Dominik
|
|
2014
|
8 |
3 |
p. 334-335
2 p.
|
artikel
|
| 85 |
Supplementation of Vitamin E in a Patient with Abetalipoproteinemia
|
Plakogiannis, Roda
|
|
2014
|
8 |
3 |
p. 329-
1 p.
|
artikel
|
| 86 |
Systemic Eicosanoid and Cytokine Response to Niacin: Implications in HPS2-THRIVE Trial and Beyond†∗
|
Song, Wenliang
|
|
2014
|
8 |
3 |
p. 309-310
2 p.
|
artikel
|
| 87 |
Table of Contents
|
|
|
2014
|
8 |
3 |
p. A3-A4
nvt p.
|
artikel
|
| 88 |
Targeting Visceral Adiposity Loss as a Mean to Optimize Vitamin D Levels? Results From a Lifestyle Intervention Study in Viscerally Obese Men*
|
Gangloff, Anne
|
|
2014
|
8 |
3 |
p. 355-
1 p.
|
artikel
|
| 89 |
The Effect of Bile Acid Sequestrants on Progression of Coronary Arterial Calcification
|
Blanchet, William L.
|
|
2014
|
8 |
3 |
p. 344-
1 p.
|
artikel
|
| 90 |
The First Functional Assay for the Detection of LDL Receptor-Specific PCSK9 in Circulation
|
Yeh, Chen-Hsiung
|
|
2014
|
8 |
3 |
p. 297-
1 p.
|
artikel
|
| 91 |
Therapeutic Lipid Target Achievements Among Highest Risk Patients: Results From the CEPHEUS Study in the Arabian Gulf States
|
Al Rasadi, Khalid Humaid
|
|
2014
|
8 |
3 |
p. 324-325
2 p.
|
artikel
|
| 92 |
Using Low-Density Lipoprotein (LDL) Particle Number (LDL-P) versus LDL Cholesterol (LDL-C) to Guide Preventative Therapy for Cardiovascular Disease
|
Folse, Henri
|
|
2014
|
8 |
3 |
p. 297-298
2 p.
|
artikel
|
Tijdschrift beschrijving